Group 1 - The second extraordinary general meeting of shareholders for Suzhou Ailong Technology Co., Ltd. was held on November 14, 2025, at the company's headquarters [2][3] - The meeting was legally convened and presided over by a director due to the absence of the chairman [3][4] - All resolutions presented at the meeting were approved without any objections [2][5] Group 2 - The meeting included the approval of significant resolutions, such as the cancellation of the supervisory board and amendments to the company's articles of association [5][6] - The company also approved the renewal of the auditing firm for the fiscal year 2025 [6] - A lawyer from Beijing Guantao Law Firm witnessed the meeting, confirming that all procedures complied with relevant laws and regulations [6]

北京观韬律师事务所 法律意见书 Tel：86 10 66578066 Fax：86 10 66578016 E-mail：guantao@guantao.com http：// www.guantao.com 中国北京市西城区金融大街 5 号 新盛大厦 B 座 19 层 邮编：100033 19/F, Tower B, Xin Sheng Plaza, No.5, Finance Street, Beijing ,100033 北京观韬律师事务所 关于苏州艾隆科技股份有限公司 2025年第二次临时股东大会的法律意见书 观意字2025BJ002858号 致：苏州艾隆科技股份有限公司 北京观韬律师事务所 法律意见书 在本法律意见书中，本所律师仅对本次股东大会会议召集和召开的程序是否 符合法律、行政法规、《规则》和《公司章程》的规定、出席本次会议现场会议 人员的资格、会议表决程序、会议表决结果是否合法有效发表意见，并不对本次 会议所审议议案的内容以及该等议案所表述的事实或数据的真实性和准确性发 表意见。本所律师假定公司提交给本所律师的资料（包括但不限于有关人员的居 民身份证、股票账户卡、授权委托书、营业执照、网络投 ...

证券代码：688329 证券简称：艾隆科技 公告编号：2025-054 苏州艾隆科技股份有限公司 2025年第二次临时股东大会决议公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次会议是否有被否决议案：无 一、 会议召开和出席情况 （一） 股东大会召开的时间：2025 年 11 月 14 日 （二） 股东大会召开的地点：苏州市工业园区新庆路 71 号艾隆科技一楼会议室 （三） 出席会议的普通股股东、特别表决权股东、恢复表决权的优先股股东及 其持有表决权数量的情况： | 1、出席会议的股东和代理人人数 | 23 | | --- | --- | | 普通股股东人数 | 23 | | 2、出席会议的股东所持有的表决权数量 | 31,144,265 | | 普通股股东所持有表决权数量 | 31,144,265 | | 3、出席会议的股东所持有表决权数量占公司表决权数量的比 | 41.8077 | | 例（%） | | | 普通股股东所持有表决权数量占公司表决权数量的比例（%） | 41.8077 | 注：上述 ...

Core Viewpoint - The stock of Elon Technology (688329) has shown a slight decline, with a closing price of 22.68 yuan on November 10, 2025, reflecting a decrease of 0.09% [1] Financial Performance - For the first three quarters of 2025, Elon Technology reported a main revenue of 280 million yuan, an increase of 25.12% year-on-year [3] - The net profit attributable to shareholders was -959,000 yuan, an increase of 96.56% year-on-year [3] - The net profit after deducting non-recurring items was -11.47 million yuan, an increase of 66.35% year-on-year [3] - In Q3 2025, the company achieved a single-quarter main revenue of 149 million yuan, up 83.53% year-on-year [3] - The single-quarter net profit attributable to shareholders was 7.43 million yuan, an increase of 182.09% year-on-year [3] - The single-quarter net profit after deducting non-recurring items was 6.62 million yuan, an increase of 160.26% year-on-year [3] Market Position - Elon Technology's total market value is 1.751 billion yuan, significantly lower than the industry average of 7.714 billion yuan, ranking 261 out of 270 [3] - The company's net assets stand at 792 million yuan, compared to the industry average of 2.271 billion yuan, ranking 207 out of 270 [3] - The company has a negative price-to-earnings ratio of -1369.48, while the industry average is 142.9 [3] - The gross profit margin is 45.79%, which is higher than the industry average of 27.68%, ranking 14 out of 270 [3] - The net profit margin is -0.92%, significantly lower than the industry average of 4.31%, ranking 220 out of 270 [3] - The return on equity (ROE) is -0.13%, compared to the industry average of 2.63%, ranking 220 out of 270 [3] Capital Flow - On November 10, 2025, the net outflow of main funds was 1.2991 million yuan, accounting for 4.0% of the total transaction amount [1][2] - Retail investors had a net inflow of 1.7578 million yuan, representing 5.42% of the total transaction amount [1][2] - Over the past five days, the stock has experienced fluctuations in capital flow, with varying net inflows and outflows from main funds, retail investors, and speculative funds [2]

Group 1 - As of October 31, 2025, Jiangsu has a total of 715 listed companies, including 220 on the Shanghai Stock Exchange Main Board, 114 on the Sci-Tech Innovation Board, 125 on the Shenzhen Stock Exchange Main Board (including one pure B-share), 203 on the Growth Enterprise Market, and 53 on the Beijing Stock Exchange [1] - In October 2025, Jiangsu added one new listed company (Changjiang Nengke), bringing the total number of new listings in 2025 to 21 [1] - The total market capitalization of the 714 listed companies in Jiangsu is 85,985.35 billion yuan, accounting for 13.12% of the total number of A-share listed companies and 8.01% of their total market capitalization [3] Group 2 - As of October 31, 2025, the companies in Jiangsu with a market capitalization exceeding 100 billion yuan (excluding the Beijing Stock Exchange) include Hengrui Medicine, WuXi AppTec, Jiangsu Bank, Guodian Nari, Huatai Securities, Nanjing Bank, Huidian Co., S. Hengli Hydraulic, Dongshan Precision, Xugong Machinery, Tianfu Communication, and Yanghe Brewery [5] - The bottom ten ranked A-share listed companies in Jiangsu (excluding the Beijing Stock Exchange) are Yangzi New Materials, Nanwei Co., Guangge Technology, Xuelang Environment, Zhongshe Co., *ST Hengjiu, Ailong Technology, Jinpu Garden, *ST Tianlong, and *ST Suwu [7] - In October 2025, Jiangsu's A-share listed companies had a total of 3 financing events, raising a total of 1.269 billion yuan, while the total financing events for the year reached 49, raising a total of 61.438 billion yuan [7]

Group 1 - The company announced a share buyback of 56,000 shares, which represents 0.0725% of its total share capital [1]

Group 1 - The company, Ailong Technology (688329.SH), announced a share buyback on October 31, 2025, through the Shanghai Stock Exchange trading system [1] - A total of 56,000 shares were repurchased, representing 0.0725% of the company's total share capital [1] - The highest price for the repurchased shares was 20.37 CNY per share, while the lowest price was 19.75 CNY per share, with a total expenditure of 1,116,560.00 CNY (excluding stamp duty and transaction fees) [1]

Group 1 - The company, Ailong Technology (688329.SH), announced a share buyback on October 31, 2025, through the Shanghai Stock Exchange trading system [1] - A total of 56,000 shares were repurchased, representing 0.0725% of the company's total share capital [1] - The highest price for the repurchased shares was 20.37 CNY per share, while the lowest price was 19.75 CNY per share, with a total expenditure of 1,116,560.00 CNY (excluding stamp duty and transaction fees) [1]

苏州艾隆科技股份有限公司 关于以集中竞价交易方式回购公司股份 的回购进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：688329 证券简称：艾隆科技 公告编号：2025-053 根据《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的相关规定，公司在回购股份期间，应于每个月的前 3 个交易日 内公告截至上月末的回购进展情况，现将公司回购股份进展情况公告如下： 2025 年 10 月 31 日，公司通过上海证券交易所交易系统以集中竞价交易方式 累计回购公司股份 56,000 股，占公司总股本的比例为 0.0725%，回购成交的最高 价为 20.37 元/股，最低价为 19.75 元/股，支付的资金总额为人民币 1,116,560.00 元 （不含印花税、交易佣金等交易费用）。 本次回购股份符合法律法规的规定及公司的回购股份方案。 三、 其他事项 公司将严格按照《上市公司股份回购规则》《上海证券交易所上市公司自律监 管指引第 7 号——回购股份》等相关规定，在回 ...

Core Viewpoint - Suzhou Ailong Technology Co., Ltd. reported significant growth in revenue and profit for Q3 2025, driven by increased orders and policy support, indicating a strong recovery in operational performance [1][2]. Group 1: Financial Performance - The company achieved a revenue of 149 million yuan in Q3, representing a year-on-year increase of 83.53% [1]. - For the first three quarters, total revenue reached 280 million yuan, up 25.12% year-on-year, with net loss narrowing to 959,000 yuan, a significant improvement of 96.56% [2]. - The net cash flow from operating activities for the first three quarters was 52.01 million yuan, a year-on-year increase of 210.86%, indicating improved cash collection and operational efficiency [2]. Group 2: Research and Development - In Q3, the company invested 15.88 million yuan in R&D, accounting for approximately 10.66% of its revenue, focusing on core technologies and product upgrades [3]. - Cumulative R&D expenditure for the first three quarters was 37.84 million yuan, maintaining a competitive position within the industry [3]. - The company is concentrating on the development of medical devices and information technology products, particularly in anesthesia and surgical information systems, positioning itself to benefit from the increasing domestic production of smart medical devices [3]. Group 3: Financial Health - As of the end of the reporting period, the company's total assets were 13.836 billion yuan, with equity attributable to shareholders amounting to 777 million yuan, reflecting a growth of 3.17% since the beginning of the year [2]. - The total liabilities slightly decreased compared to the beginning of the year, indicating a stable financial structure [2].